What is the recommended epinephrine dose for a patient in cardiac arrest caused by beta‑blocker overdose?

Epinephrine Dosing in Beta-Blocker Overdose Cardiac Arrest

For cardiac arrest secondary to beta-blocker overdose, administer the standard ACLS dose of 1 mg epinephrine IV/IO every 3–5 minutes, but be prepared to escalate to high-dose epinephrine (up to 5 mg per dose) or initiate a continuous epinephrine infusion (0.2–0.6 mg/min) if the patient fails to respond to initial standard dosing. 1, 2

Standard Initial Dosing

• Begin with 1 mg epinephrine (10 mL of 1:10,000 solution) IV or IO every 3–5 minutes during CPR, following standard ACLS protocol for all cardiac arrest rhythms. 1
• Administer the full 10 mL bolus rapidly, followed immediately by a 20 mL normal saline flush to ensure central circulation delivery. 1
• Minimize chest compression interruptions to ≤10 seconds during drug administration. 1

Escalation Strategy for Beta-Blocker Toxicity

Beta-blocker overdose creates a unique pharmacologic challenge because the beta-receptor blockade may blunt epinephrine's beneficial effects, requiring higher doses than standard cardiac arrest:

• If no response after 1–2 standard doses (1 mg each), escalate to 3–5 mg epinephrine every 3–5 minutes. 2
• Alternatively, consider transitioning to a continuous epinephrine infusion at 0.2–0.6 mg/min (200–600 mcg/min) for refractory cases. 2
• The rationale for higher dosing is that beta-blocker toxicity requires overcoming competitive receptor antagonism, and animal studies suggest standard 1 mg doses may be 5–10 times lower than needed to produce beneficial alpha-adrenergic effects in this context. 2

Adjunctive Therapy Specific to Beta-Blocker Overdose

• Strongly consider glucagon 1–5 mg IV bolus as a critical adjunct, since glucagon bypasses beta-receptors and directly activates cardiac adenylyl cyclase to restore inotropy and chronotropy. 3
• Glucagon is particularly important in beta-blocker toxicity because epinephrine's beta-agonist effects (which support cardiac contractility) will be blocked, leaving only the alpha-adrenergic vasoconstriction. 3

Route of Administration

• IV or IO is mandatory; these routes provide reliable drug delivery and are far superior to endotracheal administration. 1
• If IV/IO access is unavailable, endotracheal epinephrine requires a 10-fold higher dose (10 mg or 10 mL of 1:1000 solution), but this route has unreliable absorption and should be avoided whenever possible. 1

Pediatric Dosing Considerations

• For children in cardiac arrest from beta-blocker overdose, start with 0.01 mg/kg (0.1 mL/kg of 1:10,000) IV/IO every 3–5 minutes, with a maximum single dose of 1 mg. 4
• If standard dosing fails, escalation in pediatric patients should be guided by expert consultation, as high-dose epinephrine data in children are limited. 4

Critical Pitfalls to Avoid

• Do not use high-dose epinephrine (>1 mg) as first-line therapy; always begin with standard 1 mg dosing and escalate only if there is no response, as higher doses may worsen neurological outcomes in non-toxicologic cardiac arrest. 1, 5
• Do not confuse 1:10,000 with 1:1000 concentrations; using 1:1000 IV would cause a 10-fold overdose. 1
• Do not extend dosing intervals beyond 5 minutes; maintain the 3–5 minute schedule even when escalating doses. 1
• Do not rely solely on epinephrine in beta-blocker toxicity; glucagon is essential because beta-blockade will prevent epinephrine's beta-agonist cardiac effects from working. 3
• Do not delay epinephrine for central line placement; peripheral IV or IO access is sufficient and faster. 1

Monitoring and Response Assessment

• Assess for return of spontaneous circulation (ROSC) after each epinephrine dose. 1
• In beta-blocker overdose specifically, look for improvement in heart rate and blood pressure as indicators that the dose is overcoming receptor blockade. 3
• If ROSC is achieved but profound hypotension persists, transition to an epinephrine infusion at 0.05–2 mcg/kg/min titrated to blood pressure response. 3

Evidence Strength and Nuances

The recommendation for standard initial dosing comes from high-quality AHA guidelines 1, while the escalation strategy for beta-blocker toxicity is based on expert consensus and pharmacologic principles 2, 3. The key distinction in beta-blocker overdose is that competitive receptor antagonism may require higher epinephrine doses to achieve the same alpha-adrenergic vasoconstriction that standard doses provide in typical cardiac arrest. 2 However, prospective trials specifically examining high-dose epinephrine in toxicologic cardiac arrest are lacking, so escalation should be judicious and combined with glucagon therapy. 3, 5